F279-0267 Screening compound: 2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[3-(trifluoromethyl)phenyl]butanamide

F279-0267 Screening compound: 2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[3-(trifluoromethyl)phenyl]butanamide
F279-0267 Screening compound: 2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[3-(trifluoromethyl)phenyl]butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F279-0267
2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[3-(trifluoromethyl)phenyl]butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F279-0267

Molecular Formula

C24H21F3N4O4 (C24 H21 F3 N4 O4)

Compound Name

2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[3-(trifluoromethyl)phenyl]butanamide

IUPAC name

2-[4-(4-methoxyphenyl)-3-methyl-7-oxo-6H7H-[12]oxazolo[34-d]pyridazin-6-yl]-N-[3-(trifluoromethyl)phenyl]butanamide

SMILES

CCC(C(Nc1cccc(C(F)(F)F)c1)=O)N(C(c1noc(C)c11)=O)N=C1c(cc1)ccc1OC

InChI

InChI=1S/C24H21F3N4O4/c1-4-18(22(32)28-16-7-5-6-15(12-16)24(25,26)27)31-23(33)21-19(13(2)35-30-21)20(29-31)14-8-10-17(34-3)11-9-14/h5-12,18H,4H2,1-3H3,(H,28,32)/t18-/m0/s1

InChI Key

JJWCVDFQRQKRAI-SFHVURJKSA-N

MDL Number (MFCD)

MFCD27111348

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

486.45

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.678

Distribution Coefficient, logD

4.678

Water Solubility, LogSw

-4.57

Polar Surface Area

78.542

Acid Dissociation Constant (pKa)

10.35

Base Dissociation Constant (pKb)

0.76

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

25.00

F279-0267 in Drug Discovery

Included in Screening Libraries

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F279-0267 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F279-0267?
Check Price and Availability of F279-0267, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F279-0267 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F279-0267
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F279-0267
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F279-0267 available by request